Takara Bio Market Cap

Takara Bio has a market cap or net worth of 94.29 billion as of June 13, 2025. Its market cap has decreased by -28.30% in one year.

Market Cap

94.29B

Enterprise Value

66.19B

Revenue

45.04B

Ranking

n/a

PE Ratio

90.57

Stock Price

783.00

Market Cap Chart

Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 94.29B, an increase of 73.01%. That is a compound annual growth rate of 2.71%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	94.29B	-25.43%
Dec 30, 2024	126.44B	-16.13%
Dec 29, 2023	150.76B	-27.34%
Dec 30, 2022	207.48B	-34.83%
Dec 30, 2021	318.38B	-4.48%
Dec 30, 2020	333.31B	34.56%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	12.27T
Takeda Pharmaceutical Company	6,792.43B
Daiichi Sankyo Company	6,740.49B
HOYA Corporation	5,710.12B
Terumo	3,907.15B
Otsuka Holdings	3,828.90B
Astellas Pharma	2,485.56B
Olympus	2,159.19B

Market Cap Rankings